Aliment Pharmacol Ther

1. BAGER P, Dahlerup JF
   Letter: Post-endoscopic management after upper gastrointestinal bleeding-Replenishment of iron loss.
   Aliment Pharmacol Ther. 2024 Jul 16. doi: 10.1111/apt.18050.
   

   >> Share

   
   
2. WANG Y, Pan Y
   Letter: Reflections on the role of over-the-scope clips in high-risk upper gastrointestinal bleeding.
   Aliment Pharmacol Ther. 2024 Jul 15. doi: 10.1111/apt.18145.
   

   >> Share

   
   
3. LYU C, Yang D, Xu H, He K, et al
   Letter: Reflections on the role of over-the-scope clips in high-risk upper gastrointestinal bleeding-Authors' reply.
   Aliment Pharmacol Ther. 2024 Jul 15. doi: 10.1111/apt.18173.
   

   >> Share

   
   
4. YOON JS, Lee JH
   Letter: Risks of proton pump inhibitor treatment in cirrhotic patients-Authors' reply.
   Aliment Pharmacol Ther. 2024 Jul 12. doi: 10.1111/apt.18167.
   

   >> Share

   
   

   
   Am J Gastroenterol

5. LUNAGARIYA Y, Shah M, Lad S, Chauhan S, et al
   Comparing Short-Term Dual vs Standard Quadruple Therapy for Helicobacter pylori Eradication.
   Am J Gastroenterol. 2024 Jul 17. doi: 10.14309/ajg.0000000000002882.
   

   >> Share

   
   
6. OH JH, Kim HS, Cheung DY, Lee HL, et al
   Randomized, Double-blind, Active-controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan compared to Esomeprazole in Erosive Esophagitis.
   Am J Gastroenterol. 2024 Jul 3. doi: 10.14309/ajg.0000000000002929.
   

   >> Share

   
   

   
   Helicobacter

7. LI XT, Xu L, Zhang C, Qi YB, et al
   Improved Patient Adherence to Family-Based Helicobacter pylori Infection Control and Management Strategy in Central China and Its Influencing Factors.
   Helicobacter. 2024;29:e13114.
   

   >> Share

   
   
8. JAUVAIN M, Lepied G, Benejat L, Roudier N, et al
   Effect of Lactobacillus gasseri BIO6369 and Lacticaseibacillus rhamnosus BIO5326 on Gastric Carcinogenesis Induced by Helicobacter pylori Infection.
   Helicobacter. 2024;29:e13108.
   

   >> Share

   
   
9. MARTINEZ-DOMINGUEZ SJ, Nyssen OP, Lanas A, Alfaro E, et al
   Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg).
   Helicobacter. 2024;29:e13111.
   

   >> Share

   
   
10. CABRERA C, Torres J, Serrano CA, Gallardo P, et al
    Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008-2023): A Systematic Review.
    Helicobacter. 2024;29:e13101.
    

    >> Share

    
    
11. SAHARA S, Sugimoto M, Murata M, Iwata E, et al
    Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis: Review.
    Helicobacter. 2024;29:e13106.
    

    >> Share

    
    
12. MATSUMOTO S, Sugimoto M, Fukuzawa M, Uesugi N, et al
    Risk of map-like redness development after eradication therapy for Helicobacter pylori infection.
    Helicobacter. 2024;29:e13046.
    

    >> Share

    
    
13. ZHAO JT, Zhang Y, Wang XW, Zou PY, et al
    Long-term effects of fecal microbiota transplantation on gut microbiota after Helicobacter pylori eradication with bismuth quadruple therapy: A randomized controlled trial.
    Helicobacter. 2024;29:e13079.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

14. LIANG JW, Xiong S, Jia YG, Xiao D, et al
    Comparison of vonoprazan bismuth-containing triple therapy with quadruple therapy in Helicobacter pylori-infected treatment-naive patients: a prospective multicenter randomized controlled trial.
    J Gastroenterol Hepatol. 2024 Jul 16. doi: 10.1111/jgh.16679.
    

    >> Share

    
    

    
    Surg Endosc

15. WANG W, Liu Q, Luo L, Huang J, et al
    Value of endoscopic grading of gastroesophageal flap valve in gastroesophageal reflux disease.
    Surg Endosc. 2024 Jul 8. doi: 10.1007/s00464-024-10839.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share